Moreover, the renal survival of IgA nephropathy patients with higher than median serum IL-18 levels at baseline was approximately 20% at the end of the follow-up period (four years), and approximately 80% for total IgA nephropathy patients [310]. This evidence concerns the gene IL18 and IgA glomerulonephritis.